Literature DB >> 34253130

Revisiting social MPE: an integration of molecular pathological epidemiology and social science in the new era of precision medicine.

Jin Dai1, Akihiro Nishi1,2, Nathan Tran1, Yasumasa Yamamoto3, George Dewey1, Tomotaka Ugai4,5, Shuji Ogino4,5,6,7.   

Abstract

INTRODUCTION: Molecular pathological epidemiology (MPE) is an integrative transdisciplinary area examining the relationships between various exposures and pathogenic signatures of diseases. In line with the accelerating advancements in MPE, social science and its health-related interdisciplinary areas have also developed rapidly. Accumulating evidence indicates the pathological role of social-demographic factors. We therefore initially proposed social MPE in 2015, which aims to elucidate etiological roles of social-demographic factors and address health inequalities globally. With the ubiquity of molecular diagnosis, there are ample opportunities for researchers to utilize and develop the social MPE framework. AREAS COVERED: Molecular subtypes of breast cancer have been investigated rigorously for understanding its etiologies rooted from social factors. Emerging evidence indicates pathogenic heterogeneity of neurological disorders such as Alzheimer's disease. Presenting specific patterns of social-demographic factors across different molecular subtypes should be promising for advancing the screening, prevention, and treatment strategies of those heterogeneous diseases. This article rigorously reviewed literatures investigating differences of race/ethnicity and socioeconomic status across molecular subtypes of breast cancer and Alzheimer's disease to date. EXPERT OPINION: With advancements of the multi-omics technologies, we foresee a blooming of social MPE studies, which can address health disparities, advance personalized molecular medicine, and enhance public health.

Entities:  

Keywords:  Alzheimer’s disease; breast cancer; health inequality; heterogeneity; laboratory medicine; molecular pathological epidemiology; precision medicine; prevention; social epidemiology; social science

Mesh:

Year:  2021        PMID: 34253130      PMCID: PMC8478868          DOI: 10.1080/14737159.2021.1952073

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.670


  158 in total

1.  To boldly go....

Authors:  J B McKinlay; L D Marceau
Journal:  Am J Public Health       Date:  2000-01       Impact factor: 9.308

Review 2.  Review of inverse probability weighting for dealing with missing data.

Authors:  Shaun R Seaman; Ian R White
Journal:  Stat Methods Med Res       Date:  2011-01-10       Impact factor: 3.021

Review 3.  Non-psychiatric comorbidity associated with Alzheimer's disease.

Authors:  A Duthie; D Chew; R L Soiza
Journal:  QJM       Date:  2011-07-18

Review 4.  How many etiological subtypes of breast cancer: two, three, four, or more?

Authors:  William F Anderson; Philip S Rosenberg; Aleix Prat; Charles M Perou; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2014-08-12       Impact factor: 13.506

5.  Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients.

Authors:  Jennifer M Knight; J Douglas Rizzo; Brent R Logan; Tao Wang; Jesusa M G Arevalo; Jeffrey Ma; Steve W Cole
Journal:  Clin Cancer Res       Date:  2015-08-18       Impact factor: 12.531

Review 6.  Cognitive reserve in ageing and Alzheimer's disease.

Authors:  Yaakov Stern
Journal:  Lancet Neurol       Date:  2012-11       Impact factor: 44.182

Review 7.  Total and phosphorylated tau protein as biological markers of Alzheimer's disease.

Authors:  Harald Hampel; Kaj Blennow; Leslie M Shaw; Yvonne C Hoessler; Henrik Zetterberg; John Q Trojanowski
Journal:  Exp Gerontol       Date:  2009-10-22       Impact factor: 4.032

Review 8.  Lymphomatoid papulosis: an update and review.

Authors:  S A Martinez-Cabriales; S Walsh; S Sade; N H Shear
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-10-14       Impact factor: 6.166

9.  Metabolic reaction network-based recursive metabolite annotation for untargeted metabolomics.

Authors:  Xiaotao Shen; Ruohong Wang; Xin Xiong; Yandong Yin; Yuping Cai; Zaijun Ma; Nan Liu; Zheng-Jiang Zhu
Journal:  Nat Commun       Date:  2019-04-03       Impact factor: 14.919

Review 10.  Pharmacological Treatment of Depression in Alzheimer's Disease: A Challenging Task.

Authors:  Tommaso Cassano; Silvio Calcagnini; Antonio Carbone; Vidyasagar Naik Bukke; Stanislaw Orkisz; Rosanna Villani; Adele Romano; Carlo Avolio; Silvana Gaetani
Journal:  Front Pharmacol       Date:  2019-09-27       Impact factor: 5.810

View more
  2 in total

Review 1.  Is early-onset cancer an emerging global epidemic? Current evidence and future implications.

Authors:  Tomotaka Ugai; Naoko Sasamoto; Hwa-Young Lee; Mariko Ando; Mingyang Song; Rulla M Tamimi; Ichiro Kawachi; Peter T Campbell; Edward L Giovannucci; Elisabete Weiderpass; Timothy R Rebbeck; Shuji Ogino
Journal:  Nat Rev Clin Oncol       Date:  2022-09-06       Impact factor: 65.011

2.  Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting.

Authors:  Song Yao; Peter T Campbell; Tomotaka Ugai; Gretchen Gierach; Montserrat Garcia-Closas; Timothy R Rebbeck; Christine B Ambrosone; Shuji Ogino; Mustapha Abubakar; Viktor Adalsteinsson; Jonas Almeida; Paul Brennan; Stephen Chanock; Todd Golub; Samir Hanash; Curtis Harris; Cassandra A Hathaway; Karl Kelsey; Maria Teresa Landi; Faisal Mahmood; Christina Newton; John Quackenbush; Scott Rodig; Nikolaus Schultz; Guillermo Tearney; Shelley S Tworoger; Molin Wang; Xuehong Zhang
Journal:  Cancer Causes Control       Date:  2022-06-27       Impact factor: 2.532

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.